Completed PhD projects

Year of completion	Student	Topic	Career path
2023	Joy (Sirihathai) Srikwanjai	Synthesis of Novel Amides and Related Compounds with Applications in Medicinal Chemistry	Joy will be returning to Thailand after completing her PhD
2023	Sergi Ortoll	Synthesis of Heterocyclic Scaffolds Using Reagentless Techniques	Sergi worked as a Post Doctoral Research Fellow in SDDC and returned to Spain in July 2023
2021	Gareth Williams	Identification and characterisation of novel inhibitors of polynucleotide kinase 3’-phosphatase	Gareth is working with BenevolentAI (Cambridge, UK)
2020	Fiona Scott	Development of PKN2 chemical probes to enable drug discovery	Fiona is a medical writer
2019	James Noble	The biological and pharmacological allosteric modulation of inositol monophosphatase	James is working as Research Fellow at the UK Dementia Research Institute, King’s College
2019	Scott Henderson	Design, synthesis and characterisation of tool compounds to define the roles of serine racemase and dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) in diseases of the central nervous system	Scott is working in the United States of America
2018	Yusuf Ali	Design, synthesis and characterization of tool inhibitors targeting BLM helicase
2019	Victoria Miller	Identification of potent and selective inhibitors of the epithelial sodium channel (ENaC) delta	Victoria is training as a patent attorney
2019	Lucas Kraft	Therapeutic approaches to ApoE
2018	Ryan West	The design and synthesis of drug-like trypanosome alternative oxidase inhibitors for the treatment of African trypanosomiasis	Ryan is a Senior Scientific Officer at the CRUK Beatson Institute in Glasgow
2018	Tina (Xiangrong Chen)	Discovering inhibitors of human Bloom syndrome protein (BLM)	Tina works as a Research Fellow at the Genome Damage and Stability Centre, University of Sussex
2017	Chloe Koulouris	Identification and characterisation of a novel inhibitor of serine racemase through a fragment-based drug discovery strategy	Chloe works as Research Fellow at the Genome Damage and Stability Centre, University of Sussex
2017	Thalia Carreno Velazquez	Structure-based drug discovery approaches to identify modulators of the Nrf2 pathway and glutamate receptors AMPA GluA2 and kainate GluK1 and GluK2	Thalia works as Scientific Technician at Allergy Therapeutics
2018	Michael Paradowski	Spirooxindoles derivatives as novel inhibitors of the respiratory syncytial virus	Michael works as a Research Fellow at Cardiff University
2016	Tom Moore	Synthetic strategies towards challenging PPI drug targets
2018	Katie Duffell	Design and characterisation of tool inhibitors of DNA damage response proteins	Katie is account director at Instinctif partners